Skinvive by Juvéderm is a hyaluronic acid dermal filler used to improve skin smoothness of the cheeks, it is given by intradermal microdroplet injection. Skinvive by Juvéderm injection has been FDA-approved for patients 21 years and older, and clinical trials participants were from every Fitzpatrick Skin Type (I-VI), from the lightest to the darkest. Skinvive by Juvéderm also contains the local anesthetic lidocaine for a more comfortable injection as this numbs the treatment area within seconds.

Dermal filler injections are a nonsurgical cosmetic procedure used to plump up wrinkles, smooth lines, and restore volume in your face. A dermal filler is injected under your skin by healthcare professionals who have had appropriate training, experience, and who are knowledgeable about the anatomy of the site being treated.

Skinvive by Juvéderm will be given as an intradermal microdroplet injection by a fully trained healthcare provider. Microdroplet injections are a very small volume of gel (0.01 mL to 0.05 mL) that are spaced approximately 0.5 cm to 1 cm apart; however, placement and volume will vary based on the patient’s treatment goals. 

The typical volume to achieve optimal improvement in skin smoothness of the cheeks is 4.0 mL.

Injection volumes after repeat treatment tended to be lower, with the typical injection volume to maintain optimal effect being 2.7 mL. 

Skinvive should not be use in patients with

• severe allergies with a history of anaphylaxis or if the patient has multiple severe allergies.
• patients with a history of allergies to gram-positive bacterial proteins as Skinvive contains trace amounts of these materials
• patients with a history of allergies to lidocaine.

Skinvive is FDA-approved for patients over the age of 21.

Treatment with Skinvive should be deferred if the site to be treated is inflamed or if there are skin eruptions such as cysts, pimples, rashes, or hives. 

What should I tell my doctor before receiving Skinvive by Juvéderm

Tell your healthcare professional if you:

• are susceptible to keloid formation, hypertrophic scarring, or pigmentation disorders, as the safety Of Skinvive has not been studied in these patients. 
• are on immunosuppressive therapy
• are using substances that can increase or prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin).

Pregnancy and breastfeeding

The safety for use during pregnancy and in breastfeeding females has not been established. 

Avoid applying makeup for 12 hours after treatment, and within the first 24 hours, patients should avoid strenuous exercise, extensive sun or heat exposure, and alcoholic beverages. Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites.

What are the other Juvéderm products?

​​The Juvéderm range of products are designed to meet specific needs depending on the area of the face being treated and increase in the volume required.

Juvederm XC products also contain the local anesthetic lidocaine for a more comfortable injection as this numbs the treatment area within seconds. The Juvederm Ultra XC products contain more highly cross-linked formulations for volumizing and correction of deeper folds and wrinkles.